Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
The Transformation Partnerships for Indonesia’s Clean Energy Transition report was prepared by Synergy Policies and the Foreign Ministry’s Foreign Policy Strategy Agency over 11 months to examine how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results